Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Defronzo

Showing results (241-250 of 265) with videos related to

Pageof 27
Sort By:
Clinical Pharmacology and Therapeutics|March 16, 2007
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitusR Berria, L Glass, A Mahankali, et al.
Diabetes|October 27, 2001
Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylationW Pratipanawatr, T Pratipanawatr, K Cusi, et al.
Diabetes, Obesity & Metabolism|April 5, 2011
High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactiveE Ferrannini, D J Betteridge, J A Dormandy, et al.
The Journal of Clinical Investigation|July 1, 1993
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetesR C Bonadonna, S Del Prato, M P Saccomani, et al.
The Journal of Clinical Investigation|February 17, 2000
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscleK Cusi, K Maezono, A Osman, et al.
Acta Diabetologica|January 1, 1991
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response studyL C Groop, K Ratheiser, L Luzi, et al.
Diabetes, Obesity & Metabolism|May 28, 2011
Metabolic effects of muraglitazar in type 2 diabetic subjectsM Fernandez, A Gastaldelli, C Triplitt, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 5, 2001
Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesisP Iozzo, T Pratipanawatr, H Pijl, et al.
Diabetologia|August 1, 1988
Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patientsA Golay, R A DeFronzo, E Ferrannini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2011
Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjectsE Cersosimo, A Gastaldelli, A Cervera, et al.
Pageof 27

Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
Clinical Pharmacology and Therapeutics|March 16, 2007
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitusR Berria, L Glass, A Mahankali, et al.
Diabetes|October 27, 2001
Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylationW Pratipanawatr, T Pratipanawatr, K Cusi, et al.
Diabetes, Obesity & Metabolism|April 5, 2011
High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactiveE Ferrannini, D J Betteridge, J A Dormandy, et al.
The Journal of Clinical Investigation|July 1, 1993
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetesR C Bonadonna, S Del Prato, M P Saccomani, et al.
The Journal of Clinical Investigation|February 17, 2000
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscleK Cusi, K Maezono, A Osman, et al.
Acta Diabetologica|January 1, 1991
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response studyL C Groop, K Ratheiser, L Luzi, et al.
Diabetes, Obesity & Metabolism|May 28, 2011
Metabolic effects of muraglitazar in type 2 diabetic subjectsM Fernandez, A Gastaldelli, C Triplitt, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 5, 2001
Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesisP Iozzo, T Pratipanawatr, H Pijl, et al.
Diabetologia|August 1, 1988
Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patientsA Golay, R A DeFronzo, E Ferrannini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2011
Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjectsE Cersosimo, A Gastaldelli, A Cervera, et al.
Pageof 27